Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,648
Sort by:

Morquio Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Morquio syndrome markets are expected to exhibit a CAGR of 4.45% during 2024-2034. The Morquio syndrome market has been comprehensively analyzed in IMARC's new report titled 'Morquio Syndr...

May 2024 134 pages

Motor Neuron Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major motor neuron disease markets reached a value of US$ 6.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 11.8 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 130 pages

Mouth Neoplasms Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mouth neoplasms markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.0 Billion by 2034, exhibiting a growth rate (CAGR) of 3.69%...

May 2024 137 pages

Mucopolysaccharidoses Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mucopolysaccharidoses markets are expected to exhibit a CAGR of 5.9% during 2024-2034. The mucopolysaccharidoses market has been comprehensively analyzed in IMARC's new report titled 'Muco...

May 2024 128 pages

Mucopolysaccharidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The mucopolysaccharidosis market has been comprehensively analyzed in IMARC's new report titled 'Mucopolysaccharidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Fore...

May 2024 138 pages

Multiple Endocrine Neoplasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major multiple endocrine neoplasia markets are expected to exhibit a CAGR of 10.2% during 2024-2034. The multiple endocrine neoplasia market has been comprehensively analyzed in IMARC's new repo...

May 2024 132 pages

Multiple System Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major multiple system atrophy markets reached a value of US$ 129.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 187.2 Million by 2034, exhibiting a growth rate (CAG...

May 2024 134 pages

Muscle Spasticity Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major muscle spasticity markets reached a value of US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 6.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6.84...

May 2024 128 pages

Musculoskeletal Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major musculoskeletal pain markets reached a value of US$ 3,975.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5,399.8 Million by 2034, exhibiting a growth rate (CA...

May 2024 134 pages

Myasthenia Gravis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myasthenia gravis markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.1 Billion by 2034, exhibiting a growth rate (CAGR) of 4.99...

May 2024 134 pages

Mycosis Fungoides Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mycosis fungoides markets are expected to exhibit a CAGR of 4.9% during 2024-2034. The mycosis fungoides market has been comprehensively analyzed in IMARC's new report titled 'Mycosis Fung...

May 2024 129 pages

Mydriasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mydriasis markets are expected to exhibit a CAGR of 6.14% during 2024-2034. The mydriasis market has been comprehensively analyzed in IMARC's new report titled 'Mydriasis Market: Epidemiol...

May 2024 137 pages

Myelodysplastic Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myelodysplastic syndrome markets reached a value of US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.5 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 136 pages

Myocardial Infarction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myocardial infarction markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 137 pages

Myocarditis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myocarditis markets reached a value of US$ 1,373.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,281.7 Million by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 131 pages

Myofascial Pain Syndromes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myofascial pain syndromes markets are expected to exhibit a CAGR of 2.69% during 2024-2034. The myofascial pain syndromes market has been comprehensively analyzed in IMARC's new report tit...

May 2024 135 pages

Myopia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myopia markets are expected to exhibit a CAGR of 6.14% during 2024-2034. The myopia market has been comprehensively analyzed in IMARC's new report titled 'Myopia Market: Epidemiology, Indu...

May 2024 138 pages

Myotonic Dystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myotonic dystrophy markets reached a value of US$ 96.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 260.4 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 139 pages

Nasal Polyps Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major nasal polyps markets reached a value of US$ 68.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 109.0 Million by 2034, exhibiting a growth rate (CAGR) of 4.3% d...

May 2024 137 pages

Nasopharyngeal Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major nasopharyngeal cancer markets reached a value of US$ 858.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,075.5 Million by 2034, exhibiting a growth rate (CAG...

May 2024 128 pages

Necrotizing Enterocolitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major necrotizing enterocolitis markets reached a value of US$ 3.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.5 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 128 pages

Neonatal Sepsis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major neonatal sepsis markets are expected to exhibit a CAGR of 7.12% during 2024-2034. The neonatal sepsis market has been comprehensively analyzed in IMARC's new report titled 'Neonatal Sepsis...

May 2024 133 pages

Netherton Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Netherton syndrome markets reached a value of US$ 21.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 69.7 Million by 2034, exhibiting a growth rate (CAGR) of 1...

May 2024 132 pages

Neuroblastoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major neuroblastoma markets reached a value of US$ 256.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 328.2 Million by 2034, exhibiting a growth rate (CAGR) of 2.28...

May 2024 130 pages

Neurocutaneous Syndromes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major neurocutaneous syndromes markets are expected to exhibit a CAGR of 6.63% during 2024-2034 The neurocutaneous syndromes market has been comprehensively analyzed in IMARC's new report titled...

May 2024 138 pages

Neuroectodermal Tumors Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major neuroectodermal tumors markets are expected to exhibit a CAGR of 1.07% during 2024-2034. The neuroectodermal tumors market has been comprehensively analyzed in IMARC's new report titled 'N...

May 2024 134 pages

Neuroendocrine Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major neuroendocrine carcinoma markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 138 pages

Neurofibroma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major neurofibroma markets are expected to exhibit a CAGR of 11.2% during 2024-2034. The neurofibroma market has been comprehensively analyzed in IMARC's new report titled 'Neurofibroma Market:...

May 2024 131 pages

Neurofibrosarcoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major neurofibrosarcoma markets are expected to exhibit a CAGR of 9.6% during 2024-2034. The neurofibrosarcoma market has been comprehensively analyzed in IMARC's new report titled 'Neurofibrosa...

May 2024 129 pages

Neuromyelitis Optica Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major neuromyelitis optica markets reached a value of US$ 299.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 469.2 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 135 pages

Neuropathic Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major neuropathic pain markets reached a value of US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3.7%...

May 2024 128 pages

Neurotrophic Keratitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major neurotrophic keratitis markets reached a value of US$ 137.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 248.0 Million by 2034, exhibiting a growth rate (CAGR...

May 2024 136 pages

Niemann-Pick Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Niemann-Pick disease markets are expected to exhibit a CAGR of 4.22% during 2024-2034. The Niemann-Pick disease market has been comprehensively analyzed in IMARC's new report titled 'Niema...

May 2024 137 pages

Niemann-Pick Disease Type A Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Niemann-Pick disease type A markets are expected to exhibit a CAGR of 4.31% during 2024-2034. The Niemann-Pick disease type A market has been comprehensively analyzed in IMARC's new report...

May 2024 132 pages

Niemann-Pick Disease Type C Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Niemann-Pick disease type C markets are expected to exhibit a CAGR of 16.9% during 2024-2034. The Niemann-Pick disease type C market has been comprehensively analyzed in IMARC's new report...

May 2024 130 pages

Night Vision Disturbances Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major night vision disturbances markets reached a value of US$ 308.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 430.5 Million by 2034, exhibiting a growth rate (C...

May 2024 133 pages

Nocturia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major nocturia markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.3 Billion by 2034, exhibiting a growth rate (CAGR) of 5.93% during...

May 2024 130 pages

Nocturnal Enuresis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major nocturnal enuresis markets are expected to exhibit a CAGR of 4.84% during 2024-2034. The nocturnal enuresis market has been comprehensively analyzed in IMARC's new report titled 'Nocturnal...

May 2024 131 pages

Non-alcoholic Fatty Liver Disease (NAFLD) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

US$ 6,499.00

The 7 major Non-alcoholic fatty liver disease (NAFLD) markets reached a value of US$ 13.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 18.4 Million by 2034, exhibiting a...

May 2024 137 pages

Non Hodgkin’s Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Non Hodgkin’s lymphoma markets reached a value of US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.4 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 133 pages

Non-Small Cell Lung Cancer (NSCLC) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

US$ 6,499.00

The 7 major non-small cell lung cancer (NSCLC) markets reached a value of US$ 11.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 23.1 Billion by 2034, exhibiting a growth...

May 2024 130 pages

Nonmelanoma Skin Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major nonmelanoma skin cancer markets reached a value of US$ 467.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 621.3 Million by 2034, exhibiting a growth rate (CAG...

May 2024 140 pages

Noonan Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Noonan syndrome markets are expected to exhibit a CAGR of 3.76% during 2024-2034. The Noonan syndrome market has been comprehensively analyzed in IMARC's new report titled 'Noonan Syndrome...

May 2024 137 pages

Obsessive-Compulsive Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major obsessive-compulsive disorder markets reached a value of US$ 643.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,078.4 Million by 2034, exhibiting a growth r...

May 2024 130 pages

Obstructive Sleep Apnea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major obstructive sleep apnea markets reached a value of US$ 424.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 639.4 Million by 2034, exhibiting a growth rate (CAG...

May 2024 133 pages

Ocular Hypertension Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ocular hypertension markets reached a value of US$ 3,054.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4,538.6 Million by 2034, exhibiting a growth rate (CAG...

May 2024 131 pages

Ocular Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ocular pain markets are expected to exhibit a CAGR of 7.9% during 2024-2034. The ocular pain market has been comprehensively analyzed in IMARC's new report titled 'Ocular Pain Market: Epid...

May 2024 129 pages

Oncocytoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major oncocytoma markets are expected to exhibit a CAGR of 4.53% during 2024-2034. The oncocytoma market has been comprehensively analyzed in IMARC's new report titled 'Oncocytoma Market: Epidem...

May 2024 133 pages

Open Angle Glaucoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major open angle glaucoma markets reached a value of US$ 5.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.7 Billion by 2034, exhibiting a growth rate (CAGR) of 2....

May 2024 132 pages

Ophthalmoplegia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ophthalmoplegia markets are expected to exhibit a CAGR of 6.22% during 2024-2034. The ophthalmoplegia market has been comprehensively analyzed in IMARC's new report titled 'Ophthalmoplegia...

May 2024 130 pages

Filters

Search

Categories

790
26
203
153
137
134
125
90
65,573
803
720
771
123

Publishers

179
1
158
389
103
453
148
425
3
202
3
6
1,620
487
76
123
208
1,842
111
25
212
1,049
370
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
239
536
361
1
1,357
60
1,696
8
8,921
2,215
4,532
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
297
8
3
18
58
900
6
89
13
24
15
1,285
227
128
386
3
74
10
119
231
46
474
25
133
4

Regions

92
58
45
43
41
31
30
30
29
28
28
28
21
16
16
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
787
495
2
2
2
117
191
102
53
23
700
26
133
522
174
622
64,679

Price

Date

Pages

Offers

1
280
1
1